Insider Sheds Nearly 53,000 Shares of Consumer Health Stock, Valued at Almost $900,000
Liquidation represents 54% of insider's direct equity stake, executed at $16.78 per share following a 23% stock gain over 12 months.
Overview
Frederick Munsch, SVP, Controller and CAO of Bausch + Lomb Corporation (NYSE:BLCO), sold 52,900 shares of common stock on Aug. 10, 2026, according to a recently disclosed SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price ($16.78); post-transaction value based on Aug. 10, 2026, market close ($16.83).
Details
Bausch + Lomb Corporation is a global eye health company structured across segments, including Vision Care/Consumer Health, Ophthalmic Pharmaceuticals, and Surgical. The firm provides a portfolio ranging from contact lenses and care products to nutritional supplements and surgical equipment.
Source
Originally published at www.fool.com.